Associations - GNA11 (G Protein Subunit Alpha 11)

GNA11 mutation	Uveal Melanoma	GNA11 mutation	Uveal Melanoma	selumetinib Sensitive: C2 – Inclusion Criteria selumetinib Sensitive : C2	selumetinib Sensitive: C2 – Inclusion Criteria selumetinib Sensitive : C2
GNA11 mutation	Melanoma	GNA11 mutation	Melanoma	vorinostat Sensitive: C2 – Inclusion Criteria vorinostat Sensitive : C2	vorinostat Sensitive: C2 – Inclusion Criteria vorinostat Sensitive : C2
GNA11 mutation	Uveal Melanoma	GNA11 mutation	Uveal Melanoma	pembrolizumab Sensitive: C3 – Early Trials pembrolizumab Sensitive : C3	pembrolizumab Sensitive: C3 – Early Trials pembrolizumab Sensitive : C3
GNA11 Q209L	Uveal Melanoma	GNA11 Q209L	Uveal Melanoma	IDE196 Sensitive: C3 – Early Trials IDE196 Sensitive : C3	IDE196 Sensitive: C3 – Early Trials IDE196 Sensitive : C3
GNA11 mutation	Uveal Melanoma	GNA11 mutation	Uveal Melanoma	AEB071 Sensitive: C3 – Early Trials AEB071 Sensitive : C3	AEB071 Sensitive: C3 – Early Trials AEB071 Sensitive : C3
GNA11 Q209L	Uveal Melanoma	GNA11 Q209L	Uveal Melanoma	selumetinib Sensitive: C3 – Early Trials selumetinib Sensitive : C3	selumetinib Sensitive: C3 – Early Trials selumetinib Sensitive : C3
GNA11 mutation	Uveal Melanoma	GNA11 mutation	Uveal Melanoma	cabozantinib capsule Sensitive: C3 – Early Trials cabozantinib capsule Sensitive : C3	cabozantinib capsule Sensitive: C3 – Early Trials cabozantinib capsule Sensitive : C3
GNA11 mutation	Non Small Cell Lung Cancer	GNA11 mutation	Non Small Cell Lung Cancer	nivolumab Resistant: C3 – Early Trials nivolumab Resistant : C3	nivolumab Resistant: C3 – Early Trials nivolumab Resistant : C3
GNA11 Q209L	Melanoma	GNA11 Q209L	Melanoma	trametinib Sensitive: C3 – Early Trials trametinib Sensitive : C3	trametinib Sensitive: C3 – Early Trials trametinib Sensitive : C3
GNAQ mutation + GNA11 mutation	Uveal Melanoma	GNAQ mutation + GNA11 mutation	Uveal Melanoma	nivolumab Sensitive: C4 – Case Studies nivolumab Sensitive : C4	nivolumab Sensitive: C4 – Case Studies nivolumab Sensitive : C4
GNA11 Q209L	Uveal Melanoma	GNA11 Q209L	Uveal Melanoma	REC-4881 Sensitive: D – Preclinical REC-4881 Sensitive : D	REC-4881 Sensitive: D – Preclinical REC-4881 Sensitive : D
GNA11 Q209L	Uveal Melanoma	GNA11 Q209L	Uveal Melanoma	trametinib + GSK2126458 Sensitive: D – Preclinical trametinib + GSK2126458 Sensitive : D	trametinib + GSK2126458 Sensitive: D – Preclinical trametinib + GSK2126458 Sensitive : D

GNA11 (G Protein Subunit Alpha 11)

Associations(23)

Associations
(23)